Clinical trial • Phase I • Oncology
PF-08052667 for Non-muscle invasive bladder cancer
Phase I trial of PF-08052667 for Non-muscle invasive bladder cancer. 200 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Non-muscle invasive bladder cancer
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 23-10-2025
- First CTIS Authorization Date
- 02-03-2026
Trial design
Phase I trial across 5 sites in France, Spain.
- Target Sample Size
- 200
- Trial Duration For Participant
- 2418
Eligibility
Recruits 200 Vulnerable population not selected; no special consent or assent handling described in the CTIS record..
- Vulnerable Population
- Vulnerable population not selected; no special consent or assent handling described in the CTIS record.
Recruitment
- Planned Sample Size
- 200
- Recruitment Window Months
- 79
- Consent Approach
- No informed consent or assent process details provided in the CTIS record.
Geography
- Total Number Of Sites
- 5
- Total Number Of Participants
- 22
France
- Earliest CTIS Part Ii Submission Date
- 15-12-2025
- Latest Decision Or Authorization Date
- 02-03-2026
- Processing Time Days
- 77
- Number Of Sites
- 2
- Number Of Participants
- 11
Sites
- Site Name
- Assistance Publique Hopitaux De Paris
- Department Name
- Urologie
- Principal Investigator Name
- Morgan Roupret
- Contact Person Name
- Morgan Roupret
- Contact Person Email
- mroupret@gmail.com
- Site Name
- Institut Gustave Roussy
- Department Name
- Oncology
- Principal Investigator Name
- Yohann Loriot
- Contact Person Name
- Yohann Loriot
- Contact Person Email
- yohann.loriot@gustaveroussy.fr
Spain
- Earliest CTIS Part Ii Submission Date
- 15-01-2026
- Latest Decision Or Authorization Date
- 02-03-2026
- Processing Time Days
- 46
- Number Of Sites
- 3
- Number Of Participants
- 11
Sites
- Site Name
- Hospital Universitario 12 De Octubre
- Department Name
- Oncologia
- Principal Investigator Name
- Felix Guerrero-Ramos
- Contact Person Name
- Felix Guerrero-Ramos
- Contact Person Email
- francabreraruiz@gmail.com
- Site Name
- Hospital De La Santa Creu I Sant Pau
- Department Name
- oftalmologia & oncologia
- Principal Investigator Name
- Oscar Rodriguez Faba
- Contact Person Name
- Oscar Rodriguez Faba
- Contact Person Email
- orodriguez@fundacio-puigvert.es
- Site Name
- Fundacio Puigvert
- Department Name
- Oncologia
- Principal Investigator Name
- Oscar Rodriguez Faba
- Contact Person Name
- Oscar Rodriguez Faba
- Contact Person Email
- orodriguez@fundacio-puigvert.es
Sponsor
Primary sponsor
- Full Name
- Pfizer Inc.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United States
Investigational products
- Investigational Product Name
- PF-08052667
Related trials
Other published trials that may interest you.